Evidence map›Paper›PMID 39467112›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Asymmetric Synthesis of Dialkyl Carbinols by Ni-Catalyzed Reductive-Oxidative Relay of Distinct Alkenes.

Quan-Xing Zi, Wei Shu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Quan-Xing ZiGuangming Advanced Research Institute, Department of Chemistry, and Guangdong Provincial Key Laboratory of Catalysis Southern University of Science and Technology, Shenzhen Grubbs Institute, Shenzhen, Guangdong, 518055, P. R. China.
Wei ShuGuangming Advanced Research Institute, Department of Chemistry, and Guangdong Provincial Key Laboratory of Catalysis Southern University of Science and Technology, Shenzhen Grubbs Institute, Shenzhen, Guangdong, 518055, P. R. China.ORCID https://orcid.org/0000-0003-0890-2634

Funding

Department of Education of Guangdong Province 2022JGXM054Guangdong Provincial Department of Science and Technology 2020B121201002National Natural Science Foundation of China 22171127National Natural Science Foundation of China 22371115Science, Technology and Innovation Commission of Shenzhen Municipality JCYJ20220530114606013Science, Technology and Innovation Commission of Shenzhen Municipality JCYJ20230807093522044Sichuan Science and Technology Program 2024ZYD0017The Pearl River Talent Recruitment Program 2019QN01Y261
6 · The paper itself

Abstract

Enantioenriched unsymmetric dialkyl carbinol derivatives are of importance in natural products, bioactive molecules, and functional organic materials. However, the catalytic asymmetric synthesis of dialkyl carbinol derivatives remains challenging due to the similar steric and electronic properties of two alkyl substituents. Herein, an unprecedented synthesis of chiral dialkyl carbinol ester derivatives from Ni-catalyzed reductive-oxidative relay cross-coupling of two alkenes is developed for the first time. The reaction features the use of enol esters and unactivated alkenes as two different alkyl equivalents to undergo head-to-tail and enantioselective alkyl-alkyl cross-coupling. The reaction undergoes two-electron reduction and single electron oxidation in the presence of both reductants and oxidants. The use of an allyl bromide as single electron acceptor is crucial for the success of this non-trivial asymmetric cross-coupling, providing a new reaction mode for asymmetric alkyl-alkyl bond-forming event in the absence of stoichiometric alkyl electrophiles.

Indexed as

alkene‐alkene couplingasymmetric alkyl‐alkyl couplingdialkyl carbinolsnickel catalysisreductive‐oxidative relay

Identifiers

PMID39467112
PMCPMC11672252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.